Supernus, Inc. (SUPN) income statement
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$28.96−0.08 (-0.28%)
Close on Nov 18, 2026Market cap $3.42BP/E 8.1Yield –
Supernus, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 85.0%
- Operating margin
- 40.6%
- Net margin
- 32.8%
- Return on equity, FY2025
- -96.6%
Financial strength
- Current ratio
- 0.61
- Debt to equity
- -8.13
- Debt to assets
- 36.6%
- Cash to current liabilities
- 23.4%
Valuation
- P/E ratio
- 8.1
- Price to sales
- 2.49
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?